Medication info
Esomeprazole Magnesium Trihydrate 20 mg (Esomeprazole Magnesium Trihydrate)

Esomeprazole Magnesium Trihydrate 20 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›22.25mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Pale pink round film-coated tablet
Packaging
28 tablets/box [(7 tablets/PTP x 4)]
Approval status
Active

MFDS item code 201600519 · Approved 2016.01.26 · Insurance code 663606930

Summary

Main use
Treatment of gastrointestinal disorders (e.g., reflux, ulcers, and symptoms associated with nonsteroidal anti-inflammatory drugs) and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water; do not chew or crush it. 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once a day for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once a day. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once a day. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once a day. · In adults, 20 mg may be administered once a day as needed. In patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use, as-needed administration is not recommended for controlling subsequent symptoms. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice a day for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once a day. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once a day. Treatment duration is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once a day. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice a day. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment Administer 40 mg once a day for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. 6. Older adults No dose adjustment is necessary.
Children's dosage
Adolescents 12 years of age and older - Treatment of erosive reflux esophagitis: Administer 40 mg once a day for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once a day. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Adolescents 12 years of age and older - Once symptoms have resolved, control subsequent symptoms by administering 20 mg once a day. Children under 12 years of age - There is no experience with administration of this medicine to children under 12 years of age.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., reflux, ulcers, and symptoms associated with nonsteroidal anti-inflammatory drugs) and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis related to it. It also helps in the long-term maintenance therapy to alleviate symptoms of gastroesophageal reflux disease without esophagitis and prevent recurrence of esophagitis. It is also used in the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection. It is effective in treating gastrointestinal symptoms occurring during non-steroidal anti-inflammatory drug use, related gastric ulcers, and for the prevention of gastric and duodenal ulcers. It is used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding from gastric and duodenal ulcers. Overall, it aids in improving various symptoms and conditions related to gastrointestinal diseases.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water; do not chew or crush it. 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once a day for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once a day. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once a day. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once a day. · In adults, 20 mg may be administered once a day as needed. In patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use, as-needed administration is not recommended for controlling subsequent symptoms. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice a day for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once a day. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once a day. Treatment duration is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once a day. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice a day. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment Administer 40 mg once a day for 4 weeks after induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous treatment. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed a dose of 20 mg of this medicine. 6. Older adults No dose adjustment is necessary.

Children's dosage

Adolescents 12 years of age and older - Treatment of erosive reflux esophagitis: Administer 40 mg once a day for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. Adolescents 12 years of age and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once a day. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Adolescents 12 years of age and older - Once symptoms have resolved, control subsequent symptoms by administering 20 mg once a day. Children under 12 years of age - There is no experience with administration of this medicine to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. For example, patients who are allergic to this drug or its components or have experienced hypersensitivity reactions should not take this medication. Additionally, patients currently on certain antibiotics or medications should take caution as side effects or interactions may occur when combined with this medication. Nursing women should also avoid taking this medication, and patients with heart-related diseases or a history of myocardial infarction should avoid it. This medication may cause various adverse reactions, ranging from common symptoms like headaches, abdominal pain, diarrhea, skin rashes, and muscle pain, to rare but serious allergic reactions, liver dysfunction, and blood abnormalities. Regular testing is required for long-term use, and it is essential to consult a physician if there are changes in symptoms. This medication inhibits gastric acid secretion, which may increase the risk of bacterial overgrowth in the gastrointestinal tract; thus, if symptoms like diarrhea persist, notify healthcare professionals. Long-term use at high doses may increase the risk of fractures, so patients at risk of osteoporosis should be cautious. Additionally, this medication can lower blood magnesium levels, so routine testing of magnesium levels is necessary for long-term users. This medicine can interact with various drugs, so if taking other medications, inform healthcare providers, especially when combining with anticoagulants, antibiotics, antiviral medications, anticonvulsants, etc. During pregnancy, the safety of this medication has not been fully established, so it should only be taken under medical supervision if absolutely necessary, and should be avoided during breastfeeding. In case of overdose, there is no specific antidote, so seek immediate medical attention and keep out of reach of children. Care should be taken as transferring the medication to other containers may result in quality degradation or accidents.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reactions associated with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, flu-like symptoms, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disturbances, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal hyperpigmentation, hernia, systemic lupus erythematosus, discoid lupus erythematosus, gastric fundic gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture, at room temperature between 1 and 30 degrees Celsius. Proper storage maintains the efficacy of the medication and prevents deterioration.

Appearance and packaging

Appearance

Pale pink round film-coated tablet

Package unit

28 tablets/box [(7 tablets/PTP x 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.